Table 1.
Subject category | n (%) |
---|---|
Total | 106 (100) |
Benign | 9 (8.5) |
Renal cell carcinoma (RCC) | 97 (91.5) |
Age | Median (range) |
Total | 55.6 (28–74) |
Men | 56.1 (31–74) |
Women | 54.2 (28–70) |
Gender | |
Men | 79 (74.5) |
Women | 27 (25.5) |
Location | |
Right kidney | 43 (40.6) |
Left kidney | 62 (58.5) |
Both | 1 (0.9) |
Benign subtype | |
Renal cyst | 2 (1.8) |
Renal oncocytoma | 1 (0.9) |
Angiomyolipoma | 5 (4.7) |
Nephrotuberculosis | 1 (0.9) |
RCC subtype | |
Clear cell renal cell carcinoma (ccRCC) | 84 (79.2) |
Papillary renal cell carcinoma (pRCC) | 2 (1.8) |
Chromophobe renal cell carcinoma (chRCC) | 3 (2.8) |
Xp11.2 translocation renal cell carcinoma (Xp11_RCC) | 3 (2.8) |
Othersa | 5 (4.7) |
RCC subtype | Stage I/II/III/IVb |
all RCC | 62/4/17/14 |
ccRCC | 58/3/12/11 |
pRCC | 2/0/0/0 |
chRCC | 2/0/1/0 |
Xp11_RCC | 0/0/3/0 |
othersa | 0/1/1/3 |
Furman's grade | |
I-II | 56 (57.7) |
III-IV | 35 (36.1) |
NA | 6 (6.2) |
Concentration of preoperative plasma C-reactive protein, mg/dL | |
≦0.6 (normal) | 60 (56.6) |
>0.6 (high) | 23 (21.7) |
NA | 23 (21.7) |
Concentration of preoperative plasma fibrinogen, g/L | |
≧4 (normal) | 64 (60.4) |
>4 (high) | 16 (15.1) |
NA | 26 (24.5) |
Others: two types of pathological subtypes coexisting in one patient or unoperated patients with an undetermined pathological subtype.
Stage I/II/III/IV: number of patients with different RCC subtypes in different clinical stages.